1] Howard Hughes Medical Institute, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Pediatric Hematology/Oncology, Children's Hospital, Boston, Massachusetts 02115, USA [2] Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA [3] Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK (S.A.G.); Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, USA (C.T.L.).
1] Howard Hughes Medical Institute, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Pediatric Hematology/Oncology, Children's Hospital, Boston, Massachusetts 02115, USA [2] Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature. 2014 Jun 5;510(7503):167-71. doi: 10.1038/nature13277. Epub 2014 Apr 13.
Centrosome amplification has long been recognized as a feature of human tumours; however, its role in tumorigenesis remains unclear. Centrosome amplification is poorly tolerated by non-transformed cells and, in the absence of selection, extra centrosomes are spontaneously lost. Thus, the high frequency of centrosome amplification, particularly in more aggressive tumours, raises the possibility that extra centrosomes could, in some contexts, confer advantageous characteristics that promote tumour progression. Using a three-dimensional model system and other approaches to culture human mammary epithelial cells, we find that centrosome amplification triggers cell invasion. This invasive behaviour is similar to that induced by overexpression of the breast cancer oncogene ERBB2 (ref. 4) and indeed enhances invasiveness triggered by ERBB2. Our data indicate that, through increased centrosomal microtubule nucleation, centrosome amplification increases Rac1 activity, which disrupts normal cell-cell adhesion and promotes invasion. These findings demonstrate that centrosome amplification, a structural alteration of the cytoskeleton, can promote features of malignant transformation.
中心体扩增长期以来一直被认为是人类肿瘤的一个特征;然而,其在肿瘤发生中的作用仍不清楚。中心体扩增不能被未转化的细胞耐受,如果没有选择,多余的中心体就会自发丢失。因此,中心体扩增的高频率,特别是在更具侵袭性的肿瘤中,提出了这样一种可能性,即在某些情况下,多余的中心体可能会赋予促进肿瘤进展的有利特征。通过使用三维模型系统和其他培养人乳腺上皮细胞的方法,我们发现中心体扩增会引发细胞侵袭。这种侵袭行为类似于乳腺癌致癌基因 ERBB2 过表达所诱导的(4),并且确实增强了 ERBB2 引发的侵袭性。我们的数据表明,通过增加中心体微管成核,中心体扩增增加 Rac1 活性,破坏正常的细胞间黏附并促进侵袭。这些发现表明,中心体扩增是细胞骨架的结构改变,可以促进恶性转化的特征。